John Moore
The rapid adoption of smartphones and now touch-screen tablets (e.g., iPad) by clinicians will trigger enormous growth in the use of mHealth Apps within healthcare enterprises, with the market for mHealth in the enterprise projected to reach $1.7B by end of year 2014.
Google Health is still in the game having made a number of significant changes to its platform.
The Personal Health Record (PHR) market is fraught with challenges.
Why did Ingenix pay so much for such a small HIT vendor?
The Health Information Exchange (HIE) market is the Wild West right now.
Since its initial launch to much fanfare, Google Health has struggled to be relevant. Since its formal launch in May 2008, Google Health has not dedicated the resources to build out this platform into a truly engaging ecosystem of applications to assist the consumer in managing their health or the health of a loved one.
Yesterday, the California Health Care Foundation (CHCF) released a consumer survey report looking at perspectives on healthcare IT, privacy of personal health information (PHI) and use of internet tools, such as PHRs to manage their health or health of a loved one.
There have been a lot of discussions on the net regarding the potential impact of the iPad in the healthcare sector. At this point, there is very little agreement with some pointing to the ubiquitous nature of the iPhone in healthcare as a foreshadowing of the iPad's future impact, while others point to the modest uptake of tablet computing platforms as a precursor for minimal impact.
While the Apple iPhone was first targeted at the general consumer, Apple has been taking the necessary steps to bring this device into the enterprise, directly competing with RIM’s Blackberry. Unseating the Blackberry in many sectors, such as finance, may be near impossible but healthcare is another story.
Reading through the headlines, the press releases and checking in on today’s HIT Policy Committee meeting, it appears that the over-riding theme of comments regarding Meaningful Use rules is to relax the rules, particularly regarding reimbursement and clarify other requirements of MU to ease the burden on providers seeking to comply.